Navigation Links
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
Date:8/25/2010

SOUTH SAN FRANCISCO, Calif., Aug. 25 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved the brand name VELETRI® for the company's epoprostenol for injection therapy.  VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease.  Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.

VELETRI is an improved formulation of epoprostenol that offers greater convenience to patients than other epoprostenol formulations.  VELETRI is stable at room temperature for up to 24 hours when diluted as directed and put into the pump for administration, eliminating the need for ice packs.

"VELETRI is a proven therapy for the treatment of PAH patients who don't respond adequately to conventional treatment, and rounds out a portfolio of therapies designed to address the diverse needs of patients with this chronic and life-threatening disease," said Shal Jacobovitz, president of Actelion Pharmaceuticals US, Inc.  "As the pioneer in PAH, we are committed to transforming the lives of patients by developing efficacious therapies that also offer flexibility and convenience in treatment."

In conjunction with the launch of VELETRI, Actelion opened its fourth PAH patient registry in the United States.  PROSPECT, the registry to PROSPECTively evaluate use of VELETRI in patients with PAH, is a multicenter, observational, U.S.-based registry, which is currently ongoing.

Actelion will also provide further information on VELETRI at the American Heart Association Scientific Sessions 2010 in Chicago with a poster entitled "Biocomparability of Two Formulations of Epoprostenol, Epoprostenol for Injection (ACT-385781A) And Flolan®, Via Pharmacokinetic Assess
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
2. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
3. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
4. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
5. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
6. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
7. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
8. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
11. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
(Date:7/30/2015)... -- ResMed Inc. (NYSE: RMD ) today announced results ... the quarter was $453.1 million, a 9 percent increase ... 17 percent increase on a constant currency basis).  Net ... June 30, 2014.  Diluted earnings per share for the ... 30, 2014.  The results for the ...
(Date:7/30/2015)...  Unichem Pharmaceuticals ( USA ), Inc. ... 25 mg 1000-count bottle to the consumer level. This ... to the identification of a Clopidogrel tablet found in ... risk associated with mistakenly taking a Clopidogrel tablet instead ... experiencing Clopidogrel,s side effects which include bleeding and/or bruising. ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2
... Posit Science Corporation,announced today that enrollment has completed ... program designed to enhance memory. The,IMPACT ("Improvement in ... enrolled more than five hundred adults aged 65+,seeking ... scientific,research. Principal Investigators for the IMPACT trial ...
... PALO ALTO, Calif., Oct. 18 Avicena ... biotechnology company that,develops central nervous system therapeutics ... to the Company,s Amyotrophic,Lateral Sclerosis (ALS) drug ... International Symposium on ALS/MND which will be ...
Cached Medicine Technology:Study Demonstrates Mindful Approach to Aging 2Study Demonstrates Mindful Approach to Aging 3Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 2Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 3
(Date:7/31/2015)... Bethpage, NY (PRWEB) , ... July 31, 2015 , ... ... much as possible, even when it comes time to cook the next meal, making ... month of July by practicing best grilling tips and recipes. , Make the next ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source of ... catch a new and refreshing show on Broadway, look no further than Hamilton. This ... Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and New ...
(Date:7/31/2015)... ... July 31, 2015 , ... Cosmetic Town has ... alike on various plastic surgery procedures including, but not limited to, abdominoplasty, blepharoplasty, ... procedures like Botox and fillers. , Staying up to date with the ...
(Date:7/31/2015)... Topsfield, MA (PRWEB) , ... July 31, 2015 ... ... of this year’s “HARMONY 2015”, one of the industry’s premier thought leadership symposiums, ... Connecticut, November 5 and 6. The event attracts over 250 “C”-level executives, ...
(Date:7/31/2015)... ... ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based in Seattle, ... it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use a promising ... will grant 100% of the money raised to BioViva to help bring pioneering gene ...
Breaking Medicine News(10 mins):Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3
... Awareness of genetic testing was higher among adults in ... use of genetic testing was lower, according to data ... of Cancer Health Disparities, held Sept. 30 to Oct ... direct-to-consumers through the Internet and other venues, providing individual ...
... radiology department at a mid-sized hospital were able to ... method for measuring general technologist productivity, according to a ... the American College of Radiology ( www.jacr.org ). ... competing priorities that may be difficult to achieve simultaneously," ...
... have discovered that the over-activation of a single protein ... and facilitate the most common form of Parkinson,s disease. ... new targets for drugs already known to inhibit it, ... 1 million older Americans. Previous research demonstrated ...
... lung CT scans to improve treatment of lung cancer ... a physician-scientist at The University of Texas MD Anderson ... Institutes of Health. The award, one of 52 ... over five years to Thomas Guerrero, M.D., Ph.D., associate ...
... review article published in the October issue of ... Clinic physicians differentiate the ethical and legal permissibility ... comfort measures, specifically palliative sedation, from that of ... that palliative sedation has an important place on ...
... aboard NASA,s James Webb Space Telescope is getting its first ... Appleton Laboratory (RAL) in the United Kingdom. The Mid-InfraRed Instrument ... as diverse as the first light in the early Universe ... "The start of space simulation testing of the MIRI is ...
Cached Medicine News:Health News:Adults in Puerto Rico aware of genetic testing, but use remains low 2Health News:Parkinson's disease: Excess of special protein identified as key to symptoms and possible new target for treatment with widely used anti-cancer drug imatinib 2Health News:Parkinson's disease: Excess of special protein identified as key to symptoms and possible new target for treatment with widely used anti-cancer drug imatinib 3Health News:NIH award goes to UT MD Anderson imaging innovator Guerrero 2Health News:NIH award goes to UT MD Anderson imaging innovator Guerrero 3Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 2Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 3Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 4
... safety in the operating and recovery room, ... solution for combined haemodynamic and airway gas ... post anesthesia care units. The Cardiocap II ... providing the basic haemodynamic measurements. Two of ...
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
Medicine Products: